Joanna Smith - June 3, 2025 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2025 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Adam Gregory - April 3, 2025 Crafting IP Strategies for Innovative Biotechs Following his conversation with John Joson Ng for Nucleate Singapore Pulse, we speak to Adam ...
Adam Gregory - March 19, 2025 In vivo Cell Therapy: Breaking Free of the Chains of Ex Vivo Engineering In vivo cell therapy is emerging as a groundbreaking approach to reduce the cost and expand the ...
Adam Gregory - March 7, 2025 Hummingbird Bioscience’s multi-payload ADC technology licensed by Callio Therapeutics We are delighted to congratulate our client Hummingbird Bioscience on the successful out-licensing ...
Adam Gregory - January 30, 2025 A Meaty Victory for Impossible Foods In decision T 0425/23 of 20 December 2024, the European Patent Office (EPO) Board of Appeal (BoA) ...
Joanna Smith - October 2, 2024 Mewburn Ellis: top tier firm Legal 500 2025 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Adam Gregory - August 13, 2024 ‘It’s a 50% reduction in ageing’ Singapore startup VVB Bio promises a dramatic reduction in ageing via a single jab. Now out of ...
Adam Gregory - July 15, 2024 Mewburn Ellis is proud to have worked on 26 of the 100 top-selling pharmaceuticals of 2023 Mewburn Ellis is proud to work with some of the world’s most globally significant pharmaceuticals, ...
Adam Gregory - June 17, 2024 Podcast with Adam Gregory: protecting innovations in the biotech space Adam Gregory joins John Joson Ng on Nucleate Singapore’s Pulse podcast where he highlights success ...
Joanna Smith - October 5, 2023 Mewburn Ellis: top tier firm Legal 500 2024 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Adam Gregory - August 11, 2023 VC tips for SMEs — how do VCs evaluate the value of intellectual property? As part of a series in which we ask leading venture capitalists to answer a question of fundamental ...
Adam Gregory - June 22, 2023 Cell-cultivated chicken approved for sale in US On Wednesday 21 June 2023, the United States Department of Agriculture (USDA) approved the sale of ...
Jacqueline Murphy - March 7, 2023 Come and join us for a ‘Celebration of all things Singapore’ We are excited to be in Singapore for INTA 2023 and very much hope that you can join us at our ...
Adam Gregory - November 18, 2022 Coming soon to a plate near you? US Food and Drug Administration issue first step towards approval for cell-based meat For over a decade, the promise of cultivated meat, grown using cell-culture techniques ex vivo and ...
Jacqueline Murphy - October 14, 2022 Mewburn Ellis: top tier firm Legal 500 2023 We are extremely proud to be ranked tier one for our patent and trade mark practices in the 2023 ...
Adam Gregory - July 22, 2022 Mewburn Ellis is proud to work on 19 of the 50 top-selling pharmaceuticals of 2021 2021 was a year of unprecedented success for the biotech and pharmaceutical industries, with the ...
Rhiannon Wescott - May 3, 2022 The search for more sustainable food sources So much more than nutrition, food can evoke pleasure and excitement and bring people together. And ...
Adam Gregory - March 31, 2022 Podcast with Guy Heathers: Singapore's innovation community — trends and technology Having previously spoken to Guy Heathers, Singapore biotech entrepreneur, about the development of ...
Adam Gregory - March 30, 2022 Five patenting pitfalls in future food (and how to avoid them) In our series on future food, we have explored the exciting innovations in areas such as cultured ...
Jacqueline Murphy - October 26, 2021 New Green IP Report launched To coincide with the launch of COP26 we have released a new report into Green IP. Our report ...
Adam Gregory - September 17, 2021 Three ways future food technologies can improve the sustainability of animal feed Like many others, lockdown has changed not only the daily rhythm in my home but the members of the ...
Adam Gregory - September 9, 2021 IP priorities for future food companies The future of food is a hot topic. Whether it is cellular agriculture, next-generation meat ...
Adam Gregory - April 19, 2021 Fish-free-fish: making a splash with cellular aquaculture Whilst the oceans remain as vast and seemingly inexhaustible as ever, the old adage that “there’s ...
Adam Gregory - April 19, 2021 Jim Mellon: the reluctant gradualist taking on ageing Forward editor Caitlin Mackesy Davies learns how we might all be able to live long and prosper from ...
Adam Gregory - January 29, 2021 SARS-CoV-2 variants – reasons to be optimistic In recent weeks and months, several highly-transmissible variants of SARS-CoV-2 (the virus that ...
Adam Gregory - January 29, 2021 Conscious consumers deserve better than burgers As part of our Thought Leaders series, Director and Co-founder of Gaia Foods, Vinayaka Srinivas, ...
Adam Gregory - December 2, 2020 First regulatory approval for cultured meat – a major milestone In December 2020, US company Eat Just were granted regulatory approval by the Singapore Food Agency ...
Adam Gregory - October 27, 2020 Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115 Our client, Hummingbird Bioscience, has received regulatory authorisation to initiate clinical ...
Jacqueline Murphy - October 1, 2020 Mewburn Ellis: top tier firm Legal 500 2021 We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...
Adam Gregory - September 14, 2020 Trust at the dinner table: public perception and regulation of novel food technologies The history of humanity is the history of food technology. From the moment early hominids developed ...
Adam Gregory - August 27, 2020 Beyond cultured meat: Cellular Agriculture and animal products In recent months, lab-grown meat is getting a lot of attention. As environmental concerns and ...
Adam Gregory - August 24, 2020 Is the future of meat animal-free? Compelling advancements in cellular science could soon see us choosing to abandon animal ...
Adam Gregory - August 3, 2020 Cellular Agriculture – forecasting innovation In their recent article in Nature Food, high-profile figures in the field of Cellular Agriculture – ...
Adam Gregory - May 15, 2020 New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies Our client, Duke-NUS, has helped to develop a new, rapid serological test for determining whether ...
Adam Gregory - April 14, 2020 Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak In recent weeks there’s been a lot of discussion in the media of antibody tests relating to ...
Maria Hall - April 1, 2020 New partner promotion and director appointments We are delighted to announce five new roles across three of our offices.
Adam Gregory - February 4, 2020 Enleofen strikes Singapore’s biggest ever biotech deal In January it was announced that global pharmaceutical company Boehringer Ingelheim has acquired ...
Adam Gregory - January 30, 2020 Farming the great indoors When you think of a farm, what comes to mind? Rolling fields of green new growth, and carpets of ...
Adam Gregory - September 26, 2019 T cell engagers - dark horses of immunotherapy Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in ...
Adam Gregory - July 23, 2019 Cultured meat - food for thought Cultured meat is rapidly emerging alongside plant-and microorganism-based alternative meat products ...
Adam Gregory - June 21, 2019 Singapore biotech start-ups: the importance of patent protection Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is ...
Adam Gregory - May 17, 2019 Precision therapeutics for the precision medicine era In recent years we have seen dramatic advances in our understanding of the intricate and dynamic ...
Adam Gregory - December 10, 2018 Patent protection: five tips for biotech start-ups Early-stage biotech companies are often founded based on the exciting results of pre-clinical ...
